Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 31,579 |
|
|||||
| News | - | ||||||
| Day High | 2.34 | Low High |
|||||
| Day Low | 2.13 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.02 | -0.88% | 2.26 | 09:18:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.28 | 2.13 | 2.34 | 2.26 | 2.28 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 415 | 31,579 | US$ 2.21 | US$ 69,865 | - | 0.80 - 12.68 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:51:00 | 1 | US$ 2.25 | USD |
Incannex Healthcare Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Incannex Healthcare News
| Date | Time | Source | News Article |
|---|---|---|---|
| 16/4/2024 | 22:00 | GlobeNewswire Inc. | Incannex Healthcare Inc. Quarterly Update, Q1 2024 |
| 28/2/2024 | 23:30 | GlobeNewswire Inc. | Incannex Announces Positive Topline Results from Phase 2.. |
| 17/2/2024 | 00:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16/2/2024 | 23:30 | GlobeNewswire Inc. | Incannex Completes Successful Pre-IND Meeting with the FDA.. |
| 14/2/2024 | 22:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 01/2/2024 | 23:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01/2/2024 | 23:30 | GlobeNewswire Inc. | Clarion Clinics Open for Psychedelic-Assisted Treatments |
| 25/1/2024 | 08:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 25/1/2024 | 08:05 | GlobeNewswire Inc. | Incannex Commences Dosing in Phase 2 Clinical Trial.. |
| 19/1/2024 | 01:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19/1/2024 | 00:22 | GlobeNewswire Inc. | Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD”.. |
| 17/1/2024 | 23:30 | GlobeNewswire Inc. | Incannex Receives IRB Approval for the RePOSA Phase 2/3.. |
Historical IXHL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.43 | 2.58 | 2.13 | 2.38 | 15,473 | -0.17 | -7.00% |
| 1 Month | 3.25 | 3.60 | 2.13 | 3.05 | 23,166 | -0.99 | -30.46% |
| 3 Months | 3.51 | 8.4697 | 2.13 | 5.70 | 341,194 | -1.25 | -35.61% |
| 6 Months | 0.8724 | 12.68 | 0.80 | 5.85 | 195,719 | 1.39 | 159.06% |
| 1 Year | 2.15 | 12.68 | 0.80 | 4.87 | 130,208 | 0.11 | 5.12% |
| 3 Years | 11.00 | 90.00 | 0.80 | 7.23 | 90,975 | -8.74 | -79.45% |
| 5 Years | 11.00 | 90.00 | 0.80 | 7.23 | 90,975 | -8.74 | -79.45% |
